11th Feb 2025 Plain language summary of the TALAPRO-2 study: Talazoparib plus enzalutamide versus placebo plus enzalutamide for advanced prostate cancer with specific DNA repair gene alterations
30th Jul 2024 Plain language summary of TALAPRO-2 study: Talazoparib plus enzalutamide vs. placebo plus enzalutamide for advanced prostate cancer
30th Apr 2024 KarMMa-3 study: A plain language summary looking at the effectiveness of ide-cel for relapsed/refractory multiple myeloma
18th Jan 2024 The MOUNTAINEER study: a plain language summary looking at how effective and safe tucatinib plus trastuzumab is for treating people with metastatic colorectal cancer
17th Aug 2023 Plain Language Summary: looking at patients with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab in the CHRYSALIS study
21st Jun 2022 Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a plain language summary of the ARASENS trial
